PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
21354122-1	2011	BACKGROUND: We elucidated the difference between the effects of bezafibrate and atorvastatin in hypertriglyceridemia with apoE2/2 and 3/3.	Bezafibrate	64-75	apolipoprotein E	Homo sapiens	122-135	
9583353-0	1997	Influence of apolipoprotein E polymorphism on bezafibrate treatment response in dyslipidemic patients.	Bezafibrate	46-57	apolipoprotein E	Homo sapiens	13-29	
9583353-8	1997	These results suggest an important role of apo E polymorphism in modulating serum lipid response to bezafibrate, and phenotyping of apo E helps predict the therapeutic effect of bezafibrate treatment.	Bezafibrate	100-111	apolipoprotein E	Homo sapiens	43-48	
9583353-8	1997	These results suggest an important role of apo E polymorphism in modulating serum lipid response to bezafibrate, and phenotyping of apo E helps predict the therapeutic effect of bezafibrate treatment.	Bezafibrate	178-189	apolipoprotein E	Homo sapiens	132-137